IPA logo

ImmunoPrecise Antibodies (IPA) Accounts Receivable

Annual Accounts Receivable

$2.77 M
+$395.60 K+16.64%

April 30, 2024

Summary

Performance

1-Year Change

+16.64%

3-Year Change

+19.12%

5-Year Change

+139.44%

15-Year Change

+773.94%

IPA Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

32.82%
IPA annual accounts receivable is higher than 32.82% of companies in Healthcare sector

High & Low

All-time High

$2.77 M
IPA annual accounts receivable is currently at an all-time high

3-Year Low

$1.93 M
IPA annual accounts receivable is currently +43.37% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Apr 30, 2024
IPA previous annual earnings announcement was published on Apr 30, 2024

Next Annual Earnings Report Date

N/A
IPA next annual earnings announcement has not yet been scheduled

OtherIPAbalance sheetmetrics:

Annual Accounts Payable

$3.20 M
IPA annual accounts payable is $3.20 million

Annual Total Assets

$43.89 M
IPA annual total assets is $43.89 million

Annual Total Liabilities

$19.07 M
IPA annual total liabilities is $19.07 million

Annual Cash & Cash Equivalents

$2.53 M
IPA annual cash & cash equivalents is $2.53 million

Quarterly Accounts Receivable

$2.95 M
+$1.14 M+62.89%

October 31, 2024

Summary

Performance

3-Month Change

+62.89%

1-Year Change

+62.89%

3-Year Change

+62.89%

5-Year Change

+62.89%

IPA Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.74%
IPA quarterly accounts receivable is higher than 31.74% of companies in Healthcare sector

High & Low

All-time High

$3.07 M
IPA quarterly accounts receivable is currently -4.03% below its historical high of $3.07 million

3-Year Low

$1.70 M
IPA quarterly accounts receivable is currently +73.37% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
IPA previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
IPA next earnings announcement is scheduled for Mar 14, 2025

OtherIPAbalance sheetmetrics:

Quarterly Accounts Payable

$3.87 M
IPA quarterly accounts payable is $3.87 million

Quarterly Total Assets

$43.11 M
IPA quarterly total assets is $43.11 million

Quarterly Total Liabilities

$19.62 M
IPA quarterly total liabilities is $19.62 million

Quarterly Cash And Cash Equivalents

$2.54 M
IPA quarterly cash and cash equivalents is $2.54 million

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

IPA Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+16.6%+62.9%
3 y3 years+19.1%+62.9%
5 y5 years+139.4%+62.9%

IPA Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+43.4%at high+73.4%
5 y5-yearat high+139.4%-4.0%+78.4%
alltimeall timeat high>+9999.0%-4.0%-100.0%

ImmunoPrecise Antibodies Accounts Receivable History

DateAnnualQuarterly
Oct 2024
-
$2.95 M(+62.9%)
Jul 2024
-
$1.81 M(-34.7%)
Apr 2024
$2.77 M(+16.6%)
$2.77 M(+22.0%)
Jan 2024
-
$2.27 M(-13.1%)
Oct 2023
-
$2.62 M(-2.6%)
Jul 2023
-
$2.69 M(+13.0%)
Apr 2023
$2.38 M(+22.9%)
$2.38 M(+39.7%)
Jan 2023
-
$1.70 M(-28.2%)
Oct 2022
-
$2.37 M(+13.7%)
Jul 2022
-
$2.09 M(+7.9%)
Apr 2022
$1.93 M(-16.9%)
$1.93 M(+0.2%)
Jan 2022
-
$1.93 M(+9.8%)
Oct 2021
-
$1.76 M(-20.5%)
Jul 2021
-
$2.21 M(-5.1%)
Apr 2021
$2.33 M(+30.8%)
$2.33 M(-12.4%)
Jan 2021
-
$2.66 M(-13.5%)
Oct 2020
-
$3.07 M(+14.6%)
Jul 2020
-
$2.68 M(+50.7%)
Apr 2020
$1.78 M(+53.7%)
$1.78 M(+7.6%)
Jan 2020
-
$1.65 M(+18.0%)
Oct 2019
-
$1.40 M(+37.4%)
Jul 2019
-
$1.02 M(-11.9%)
Apr 2019
$1.16 M(-10.4%)
$1.16 M(+32.3%)
Jan 2019
-
$875.40 K(-47.4%)
Oct 2018
-
$1.66 M(+71.8%)
Jul 2018
-
$968.80 K(-25.1%)
Apr 2018
$1.29 M(+307.4%)
$1.29 M(+36.9%)
Jan 2018
-
$944.50 K(-3.6%)
Oct 2017
-
$979.90 K(+72.9%)
Jul 2017
-
$566.70 K(+78.6%)
Apr 2017
$317.30 K(>+9900.0%)
$317.30 K(+7.1%)
Jan 2017
-
$296.30 K(>+9900.0%)
Jun 2016
-
$1000.00(+25.0%)
Mar 2016
-
$800.00(+33.3%)
Dec 2015
$600.00(-64.7%)
-
Dec 2015
-
$600.00(>+9900.0%)
Sep 2015
-
$0.00(0.0%)
Jun 2015
-
$0.00(-100.0%)
Mar 2015
-
$10.90 K(+541.2%)
Dec 2014
$1700.00(+70.0%)
-
Dec 2014
-
$1700.00(+54.5%)
Sep 2014
-
$1100.00(+450.0%)
Jun 2014
-
$200.00(-88.2%)
Mar 2014
-
$1700.00(+70.0%)
Dec 2013
$1000.00(-90.7%)
-
Dec 2013
-
$1000.00(-87.7%)
Sep 2013
-
$8100.00(-30.2%)
Jun 2013
-
$11.60 K(+2.7%)
Mar 2013
-
$11.30 K(+5.6%)
Dec 2012
$10.70 K(-50.2%)
-
Dec 2012
-
$10.70 K(-54.5%)
Sep 2012
-
$23.50 K(+9.3%)
Dec 2011
$21.50 K(+465.8%)
-
Dec 2011
-
$21.50 K(+258.3%)
Sep 2010
-
$6000.00(-10.4%)
Jun 2010
-
$6700.00(+59.5%)
Mar 2010
-
$4200.00
DateAnnualQuarterly
Dec 2009
$3800.00(-88.6%)
-
Dec 2009
-
$3800.00(-85.1%)
Sep 2009
-
$25.50 K(-10.5%)
Jun 2009
-
$28.50 K(-37.1%)
Mar 2009
-
$45.30 K(+36.4%)
Dec 2008
$33.20 K(+53.0%)
-
Dec 2008
-
$33.20 K(-53.8%)
Sep 2008
-
$71.80 K(+67.0%)
Jun 2008
-
$43.00 K(+367.4%)
Mar 2008
-
$9200.00(-57.6%)
Dec 2007
$21.70 K(-49.1%)
-
Dec 2007
-
$21.70 K(+43.7%)
Sep 2007
-
$15.10 K(-18.8%)
Jun 2007
-
$18.60 K(+244.4%)
Mar 2007
-
$5400.00(-87.3%)
Dec 2006
$42.60 K(+407.1%)
-
Dec 2006
-
$42.60 K(-51.9%)
Sep 2006
-
$88.50 K(+150.7%)
Jun 2006
-
$35.30 K(+566.0%)
Mar 2006
-
$5300.00(-36.9%)
Dec 2005
$8400.00(-52.8%)
-
Dec 2005
-
$8400.00(-88.6%)
Sep 2005
-
$73.80 K(-19.8%)
Jun 2005
-
$92.00 K(+648.0%)
Mar 2005
-
$12.30 K(-30.9%)
Dec 2004
$17.80 K(-80.9%)
-
Dec 2004
-
$17.80 K(-45.1%)
Sep 2004
-
$32.40 K(-58.6%)
Jun 2004
-
$78.30 K(+675.2%)
Mar 2004
-
$10.10 K(-89.2%)
Dec 2003
$93.30 K(+7675.0%)
-
Dec 2003
-
$93.30 K(+141.7%)
Sep 2003
-
$38.60 K(+1578.3%)
Jun 2003
-
$2300.00(-74.2%)
Mar 2003
-
$8900.00(+641.7%)
Dec 2002
$1200.00(-47.8%)
-
Dec 2002
-
$1200.00(-36.8%)
Sep 2002
-
$1900.00(+5.6%)
Jun 2002
-
$1800.00(-21.7%)
Mar 2002
-
$2300.00(0.0%)
Dec 2001
$2300.00(-98.6%)
-
Dec 2001
-
$2300.00(>+9900.0%)
Sep 2001
-
$0.00(-100.0%)
Jun 2001
-
$121.80 K(-14.8%)
Mar 2001
-
$142.90 K(-13.4%)
Dec 2000
$165.00 K(>+9900.0%)
-
Dec 2000
-
$165.00 K(+403.0%)
Sep 2000
-
$32.80 K(+662.8%)
Jun 2000
-
$4300.00(+95.5%)
Mar 2000
-
$2200.00(+100.0%)
Dec 1999
$1100.00(-68.6%)
-
Dec 1999
-
$1100.00(-68.6%)
Dec 1998
$3500.00(-57.3%)
-
Dec 1998
-
$3500.00(-57.3%)
Dec 1997
$8200.00(+24.2%)
-
Dec 1997
-
$8200.00
Dec 1996
$6600.00
-

FAQ

  • What is ImmunoPrecise Antibodies annual accounts receivable?
  • What is the all time high annual accounts receivable for ImmunoPrecise Antibodies?
  • What is ImmunoPrecise Antibodies annual accounts receivable year-on-year change?
  • What is ImmunoPrecise Antibodies quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for ImmunoPrecise Antibodies?
  • What is ImmunoPrecise Antibodies quarterly accounts receivable year-on-year change?

What is ImmunoPrecise Antibodies annual accounts receivable?

The current annual accounts receivable of IPA is $2.77 M

What is the all time high annual accounts receivable for ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies all-time high annual accounts receivable is $2.77 M

What is ImmunoPrecise Antibodies annual accounts receivable year-on-year change?

Over the past year, IPA annual accounts receivable has changed by +$395.60 K (+16.64%)

What is ImmunoPrecise Antibodies quarterly accounts receivable?

The current quarterly accounts receivable of IPA is $2.95 M

What is the all time high quarterly accounts receivable for ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies all-time high quarterly accounts receivable is $3.07 M

What is ImmunoPrecise Antibodies quarterly accounts receivable year-on-year change?

Over the past year, IPA quarterly accounts receivable has changed by +$1.14 M (+62.89%)